Health Ministry Halts Use of Specific Similac Batch After Complaint
Translated & summarized from Kipa by baba
Israel's Ministry of Health has stopped the use of a specific batch of Similac infant formula in hospitals after a single complaint. The manufacturer is providing an alternative batch while an investigation is underway.
The story in 5 lines · by baba
- Health Ministry halts use of specific Similac batch in hospitals.
- Decision follows a single complaint about batch 89203N201.
- Formula is hospital-exclusive, not sold in retail.
- No adverse health effects reported.
- Manufacturer supplying alternative batch.
Israel's Ministry of Health announced Sunday that it has temporarily halted the use of a specific batch of Similac infant formula intended solely for hospital use. The decision follows a single, isolated complaint received Saturday evening regarding batch number 89203N201.
"At this stage, this is a single complaint," the ministry stated, emphasizing that the affected batch is distributed only to hospitals and not sold in retail stores. The ministry is awaiting the completion of an investigation into the matter. No reports of adverse health effects related to the complaint have been received.
Abbott, the manufacturer, is working to supply an alternative batch to hospitals. The ministry clarified that this directive applies exclusively to the identified batch and does not affect other Similac batches currently in circulation.
Mentioned
